Massachusetts Financial Services’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $943K | Buy |
55,465
+686
| +1% | +$11.7K | ﹤0.01% | 813 |
|
|
2025
Q1 | $1.07M | Sell |
54,779
-1,248
| -2% | -$24.4K | ﹤0.01% | 804 |
|
|
2024
Q4 | $1.39M | Sell |
56,027
-1,671
| -3% | -$41.4K | ﹤0.01% | 785 |
|
|
2024
Q3 | $1.41M | Sell |
57,698
-1,397
| -2% | -$34.2K | ﹤0.01% | 767 |
|
|
2024
Q2 | $1.38M | Buy |
+59,095
| New | +$1.38M | ﹤0.01% | 775 |
|
|
2023
Q2 | – | Sell |
-10,409
| Closed | -$319K | – | 825 |
|
|
2023
Q1 | $319K | Sell |
10,409
-10,498
| -50% | -$321K | ﹤0.01% | 818 |
|
|
2022
Q4 | $818K | Buy |
20,907
+1,557
| +8% | +$60.9K | ﹤0.01% | 790 |
|
|
2022
Q3 | $922K | Buy |
+19,350
| New | +$922K | ﹤0.01% | 787 |
|